Cancer: Stem cell therapy offers hope
Published on: Friday, June 06, 2025
Published on: Fri, Jun 06, 2025
By: David Thien Text Size: Dr Jaswant (left) receiving a memento from Dr Su. Kota Kinabalu: Side effects of chemotherapy can be treated with stem cell therapy, part of regenerative medicine that is touted as the future of healthcare to cure various diseases, including leukaemia. Oncologist at KPJ Sabah Specialist Hospital Dato' Dr Jaswant Singh, said immunotherapy helps in destroying or slowing down and shrinking cancerous tumours.
Advertisement 'It stimulates or modifies the immune system. Stem cell therapy and immunotherapy can be combined to create new approaches for treating cancer,' he said. He was speaking on the 'Future of Regenerative Medicine' at a 'Generative Medicine & Biotech' seminar themed 'Restoring Health Naturally' at Hakka Hall on Monday, organised by Biolive, AIBTL Biopharma and ABVC Biopharma. Stem cell therapy is known as regenerative medicine that promotes the repair response of damaged tissues or organs. "These stem cells grow in a lab and can be manipulated to specialise in specific types of cells. 'Potential diseases that can be treated with stem cell therapy include heart disease, stroke, COPD, respiratory infections, Alzheimer's diseases, Parkinson's diseases, and diabetes,' he said. 'Regenerative medicine aims to replace damaged tissues or organs due to age, diseases, and trauma. Examples of regenerative medicine include stem cell therapy, 3D tissue engineering, and regenerative injection therapy,' he said. The panel of speakers included former Director-General of Health, Dr Noor Hisham Abdullah, Prof. Dr Su Yung Tsun, the Director of Taiwan Anti-Aging Medical Association and Associate Prof. Dr Angela Ng of UKM Medical Centre's Department of Tissue Engineering and Regenerative Medicine. Dr Jaswant Singh noted that Malaysians like badminton icon Datuk Lee Chong Wei went to seek treatment for cancer in Taiwan, which has proton beam radiotherapy that is sometimes used for very rare sinus cancers. Many other countries have yet to set up such expensive equipment. For example, the Chang Gung Memorial Hospital Proton and Radiation Therapy Centre is the largest proton therapy centre of Southeast Asia and is also the first proton therapy centre in Taiwan, with costs lower than that of Singapore. Prof. Dr Su Yung Tsun, the Director of Taiwan Anti-Aging Medical Association said the government is very supportive of new treatments. Proton therapy uses protons (positively charged particles) to treat cancer. It may also be called proton beam therapy. It uses proton beams instead of x-ray beams. Protons release more energy after reaching a certain distance and then stop, while x-ray beams release energy before and after they hit their target. So protons cause less damage to tissues they pass through before reaching their target. Proton therapy causes the least amount of damage to nearby healthy tissues. In other words, unlike x-rays, which go through the patient and expose the body to radiation both before and after they hit the tumour, protons stop moving after traveling a certain distance. So the tissues behind the tumour are almost protected from radiation and even tissues in front of the tumour are exposed to less radiation than the tumour. This means that proton beam radiation can deliver radiation to the cancer while doing less damage to nearby normal tissues. Because there are so many critical structures close by, proton beam radiation can be used to treat certain tumours of the nasal cavity or paranasal sinuses. Right now, proton beam therapy is not widely available. The machines needed to make protons are very expensive, and they aren't available in many countries now.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Focus Malaysia
10 hours ago
- Focus Malaysia
Delay on GP fee review: 'Face realities on the ground,' NACCOL told
A DOCTORS' group has expressed disappointment over the government's failure to to revise private general practitioners' (GP) consultation fees as promised. 'We note with deep disappointment that the Health Minister's promise to finalise the long-overdue review of private GP consultation fees within a month has now passed without action,' said Federation of Private Medical Practitioners' Associations, Malaysia (FPMPAM) president Dr Shanmuganthan TV Ganeson. 'Private GPs have been self-funding the essential primary care system for decades. Yet we remain shackled by consultation fees that have not changed in 33 years, while regulations and compliance costs continue to rise.' Recall that Health Minister Datuk Seri Dzulkefly Ahmad told reporters on May 3 that the issue about GP consultation fees would be resolved 'within one month at the latest', adding that he had already prepared a Cabinet memorandum and circular. During Dzulkefly's May 3 press conference, the Health Minister claimed that the National Action Committee on the Cost of Living (NACCOL) had already agreed to a review of GP consultation fees. 'The Malaysian Medical Association and other GP bodies have presented a clear, evidence-based case for a fee update that ensures the sustainability of primary care clinics and the quality of care for our patients,' Dr Shanmuganathan said. 'We understand that NACCOL has raised concerns about the impact of the fee update. We want to remind NACCOL that these concerns are misplaced. 'Patients who visit GPs choose to do so for immediate, quality care—often to avoid hospital queues and costly specialist visits. They are willing to pay a fair fee for this timely service. 'Past analyses by NACCOL itself showed no significant impact on the Consumer Price Index, even with proposed fee updates as far back as 2019.' Moreover, Dr Shanmuganathan noted that third-party administrators have for too long suppressed GP consultation fees for corporate profit, while the Pharmaceutical Services Division, certain pharmacy groups, and even Pharma Corporations have lobbied to undermine the integrated GP clinic model that has served Malaysians well for over 60 years. 'The government must not hide behind a narrative that keeping GP fees artificially low somehow serves the public good,' he stressed. 'In reality, it threatens the survival of primary care—the most cost-effective part of our healthcare system—and shifts costs to patients in other ways. 'NACCOL must face these realities. It must not deny GPs the means to sustain their practices and continue serving communities effectively. 'We call on the Health Minister to honour his promise and on NACCOL to remove its obstacles and allow this long-overdue correction. Anything less is a disservice to GPs and the communities we care for daily.' ‒ June 6, 2025 Main image: The Straits Times
Malaysiakini
14 hours ago
- Malaysiakini
Of Malaysian healthcare and its financing
LETTER | On May 29, a gathering of 200-plus filled the venue for a public forum on medical inflation and its contributory causes, organised by medical and health sciences students at Universiti Malaya. An earlier forum in April 2025 had focused on stakeholders' firefighting priorities in the immediate aftermath of steep hikes in health insurance premiums. The recent follow-up forum was an opportunity to address more systemic aspects of Malaysian healthcare and its financing. The keynote address by Dr Aneil Moorthy, in my interpretation (and rearrangement) of its component parts, was a way of answering the question: Why do we need private health insurance? The answer I arrived at was chronic underfunding of public sector healthcare, which has obliged many Malaysians to prepare for contingencies if faced with congested public hospitals and long queues and delays when seeking urgently needed inpatient care. For those without deep pockets, such contingency plans invariably look to commercial hospitals and the requisite insurance coverage for critical care if and when its need arises. That, sadly, is the backdrop to the recent public uproar over premium hikes for hospitalisation insurance, if one is unfortunate enough to get entangled in a tug-of-war between profit-driven overtreatment ('the vendor tells the buyer what the buyer must buy') and profit-driven insurers' denial of coverage and treatment ('the high-risk cases who are most likely to need healthcare, will be the individuals least likely to get coverage or treatment when they need it'). It's not me, look over there Association of Private Hospitals of Malaysia's president Dr Kuljit Singh unfortunately declined an invitation as a much-needed panellist, but he was present nonetheless for a watching brief on behalf of APHM's member hospitals. His occasional protagonist, Life Insurance Association of Malaysia CEO Mark O'Dell, deftly explained why insurers were not the sole culprits deserving of brickbats and deflected blame from irate policyholders (and hospitals), for the steep hikes (40 percent-70 percent) in health insurance premiums for 2025. Despite five and a half hours of animated exchanges (yes, audience engagement was that sustained), time did not allow for me to ask O'Dell a second question from the floor: Should profit-driven risk-rated healthcare insurers have any role in healthcare financing? Should Bank Negara Malaysia, as the insurance regulator, allow only uniform, community-rated health insurance which was non-discriminatory of risk sub-groups? (In effect, mandate cross-subsidies as an unavoidable feature of risk pooling and sustainable risk management in health insurance) A primary care detour Malaysian Medical Association president-elect Dr Thirunavukarasu Rajoo rightly emphasised the key role of primary care in a comprehensive national response to our ongoing epidemics of noncommunicable diseases (NCDs). With the added involvement of other health-related personnel and civil society organisations, it could contribute importantly towards cost control by pre-emptively reducing the need for expensive referrals for higher levels of care and inpatient services. Notably, he did not dwell at length on GPs' discontent over medicines price labelling and its underlying complications of stagnant GP consultation fees, (compensating) increased & opaque mark-ups on dispensed medicines, patients upset with prescribing fee on top of consultation fee, pharmacists wanting dispensing fee too, etc (sympathies for Health Minister Dzulkefly Ahmad. I wonder if a meaningful solution for these problems is possible without considering [flexible] separation of prescribing and dispensing). Healthcare cost ≠ medical bills Just as the primary care response to NCDs entails promotive, preventive (and in the near future, predictive?) care as well (i.e. much more than just prescriptions and medications), academic Nirmala Bhoo Pathy made an important point, from a patient perspective, that health-seeking costs do not equate to medical bills. She eloquently pointed out that a more meaningful listing would include 'health-related costs beyond medical bills: transport, lost income, special diets, caregiving… real cost protection requires cross-sector solutions across social welfare, transport, labour, local governments, and NGOs'. Sourcing for increased Health Ministry allocations Did special guest Khairy Jamaluddin signal that 'KJ akan kembali, selepas Keluar Sekejap?' (KJ will be back after Keluar Sekejap?) Khairy was the first health minister who publicly acknowledged, during his short tenure, that the Health Ministry was chronically underfunded and that he would seek a doubling of federal allocations to five percent of GDP within five years. In his closing remarks at the Health Policy Summit 2022: Future of Our Healthcare - Health White Paper Development, he candidly remarked that he had pointedly avoided the 'i' word (insurance) in the preceding two days because he didn't want to get embroiled in a discussion on Social Health Insurance. Unfortunately, he left the forum early, and I missed a chance to ask if he still favoured SHI labour taxes as a principal source for doubling the ministry's allocations, despite extensive, consistent evidence (Yazbeck et al, 2020; Wagstaff, 2009) that tax-funded healthcare systems outperformed SHI-funded healthcare systems. During his articulate presentation, Khairy did concede, as did former deputy health minister Dr Lee Boon Chye, that the most urgent task was to upgrade, reinforce, and reform an adequately funded public healthcare delivery system before asking the public to consider supplementary taxes for further system improvements, or increased patient co-payments at point of service. Lee further remarked that RakanKKM was, in his opinion, a band-aid stopgap that was unlikely to significantly improve affordable access, perhaps could even degrade the quality of care for regular patients. By way of concluding, kudos are due for the excellent organising abilities and attention to detail of the UM students who convened this event. It is indeed encouraging that medical and biomedical undergraduates are going beyond their usual preoccupations with clinical and laboratory skills to engage with urgent health system and health policy priorities on the national agenda. CHAN CHEE KHOON is the coordinator of Citizens' Health Initiative. The views expressed here are those of the author/contributor and do not necessarily represent the views of Malaysiakini.
Daily Express
15 hours ago
- Daily Express
Cancer: Stem cell therapy offers hope
Published on: Friday, June 06, 2025 Published on: Fri, Jun 06, 2025 By: David Thien Text Size: Dr Jaswant (left) receiving a memento from Dr Su. Kota Kinabalu: Side effects of chemotherapy can be treated with stem cell therapy, part of regenerative medicine that is touted as the future of healthcare to cure various diseases, including leukaemia. Oncologist at KPJ Sabah Specialist Hospital Dato' Dr Jaswant Singh, said immunotherapy helps in destroying or slowing down and shrinking cancerous tumours. Advertisement 'It stimulates or modifies the immune system. Stem cell therapy and immunotherapy can be combined to create new approaches for treating cancer,' he said. He was speaking on the 'Future of Regenerative Medicine' at a 'Generative Medicine & Biotech' seminar themed 'Restoring Health Naturally' at Hakka Hall on Monday, organised by Biolive, AIBTL Biopharma and ABVC Biopharma. Stem cell therapy is known as regenerative medicine that promotes the repair response of damaged tissues or organs. "These stem cells grow in a lab and can be manipulated to specialise in specific types of cells. 'Potential diseases that can be treated with stem cell therapy include heart disease, stroke, COPD, respiratory infections, Alzheimer's diseases, Parkinson's diseases, and diabetes,' he said. 'Regenerative medicine aims to replace damaged tissues or organs due to age, diseases, and trauma. Examples of regenerative medicine include stem cell therapy, 3D tissue engineering, and regenerative injection therapy,' he said. The panel of speakers included former Director-General of Health, Dr Noor Hisham Abdullah, Prof. Dr Su Yung Tsun, the Director of Taiwan Anti-Aging Medical Association and Associate Prof. Dr Angela Ng of UKM Medical Centre's Department of Tissue Engineering and Regenerative Medicine. Dr Jaswant Singh noted that Malaysians like badminton icon Datuk Lee Chong Wei went to seek treatment for cancer in Taiwan, which has proton beam radiotherapy that is sometimes used for very rare sinus cancers. Many other countries have yet to set up such expensive equipment. For example, the Chang Gung Memorial Hospital Proton and Radiation Therapy Centre is the largest proton therapy centre of Southeast Asia and is also the first proton therapy centre in Taiwan, with costs lower than that of Singapore. Prof. Dr Su Yung Tsun, the Director of Taiwan Anti-Aging Medical Association said the government is very supportive of new treatments. Proton therapy uses protons (positively charged particles) to treat cancer. It may also be called proton beam therapy. It uses proton beams instead of x-ray beams. Protons release more energy after reaching a certain distance and then stop, while x-ray beams release energy before and after they hit their target. So protons cause less damage to tissues they pass through before reaching their target. Proton therapy causes the least amount of damage to nearby healthy tissues. In other words, unlike x-rays, which go through the patient and expose the body to radiation both before and after they hit the tumour, protons stop moving after traveling a certain distance. So the tissues behind the tumour are almost protected from radiation and even tissues in front of the tumour are exposed to less radiation than the tumour. This means that proton beam radiation can deliver radiation to the cancer while doing less damage to nearby normal tissues. Because there are so many critical structures close by, proton beam radiation can be used to treat certain tumours of the nasal cavity or paranasal sinuses. Right now, proton beam therapy is not widely available. The machines needed to make protons are very expensive, and they aren't available in many countries now.
